Offering another clinical application to the genomic approach, Verhaak and colleagues have published a framework for integrated genomic analysis that identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1 [13] utilizing recurrent genomic abnormalities. The gene discussed is IDH1; the disease is glioblastoma.